Company: HCTI
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001213900-25-109581
Chunk: 157

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 2
Chunk 157
---
.

Key Factors of Success

We believe that our future growth, success, and
performance are dependent on many factors, including those mentioned below. While these factors present significant opportunities for
us, they also represent the challenges that we must successfully address in order to grow our business and improve our results of operations.

Investment in scaling the business 

We need to continuously invest in sales, and
marketing to promote our solutions to new and existing customers in various geographies, and other operational and administrative functions
in systems, controls and governance to support our expected growth and our transition to a public company. We anticipate that our employee
strength will increase over time because of such investments.

On June 16, 2025 (the “Closing date”),
Healthcare Triangle, Inc. through its wholly owned subsidiary Quantum Nexus Inc. (the “Company”) and Niyama Healthcare, Inc.,
a Delaware corporation, a provider of Mental Health and Hospital Information Systems technology, across India, South East Asia, and Europe
(the “Seller”) entered into an Asset and Stock Transfer Agreement (the “Agreement”). Pursuant to the Agreement,
the Company agreed to purchase from the Seller the Transferred Assets (comprising of contracts, intellectual property and related assets),
and (ii) the Seller’s 100% shareholder equity interest in Ezovion Solutions Private Limited, Chennai, India - Hospital Information
Systems SaaS Provider as Seller’s Equity (the “Transferred Equity”), as a whole and as a going concern in exchange
for the Purchase Price (as defined below).

The total consideration for the acquisition, which is referred to herein
as the “Purchase Price”, is $5,700 which includes: (1) $1,500 in cash, of which $1,200 is due on the Closing Date and $300
to be paid at the later of the satisfaction of certain withholding requirements or within 120 days of the Closing Date; during the period
ended September 30, 2025, the Company made payments amounting to $1,045 out of the $1,500 obligation. The remaining balance of $455 is
recognized as payable as at September 30, 2025. (2) 1,388,041 shares of restricted common stock of the Company equal to $3,000 divided
by $2.16, issued on the Closing Date; and (3) up to $1,200 in earn-out payments contingent on first-year financial performance targets
to be agreed upon mutually.

The final